[1]

Vujosevic S, Parra MM, Hartnett ME, O’Toole L, Nuzzi A, et al. 2023. Optical coherence tomography as retinal imaging biomarker of neuroinflammation/neurodegeneration in systemic disorders in adults and children. Eye 37:203−219

doi: 10.1038/s41433-022-02056-9
[2]

Barber AJ. 2015. Diabetic retinopathy: recent advances towards understanding neurodegeneration and vision loss. Science China Life Sciences 58:541−549

doi: 10.1007/s11427-015-4856-x
[3]

Carpineto P, Toto L, Aloia R, Ciciarelli V, Borrelli E, et al. 2016. Neuroretinal alterations in the early stages of diabetic retinopathy in patients with type 2 diabetes mellitus. Eye 30:673−679

doi: 10.1038/eye.2016.13
[4]

Antonetti DA, Klein R, Gardner TW. 2012. Diabetic retinopathy. New England Journal of Medicine 366:1227−1239

doi: 10.1056/nejmra1005073
[5]

Sohn EH, van Dijk HW, Jiao C, Kok PHB, Jeong W, et al. 2016. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proceedings of the National Academy of Sciences of the United States of America 113:E2655−E2664

doi: 10.1073/pnas.1522014113
[6]

Hui Z, Guo X, Bulloch G, Yuan M, Xiong K, et al. 2024. Rates of choroidal loss and ganglion cell–inner plexiform layer thinning in type 2 diabetes mellitus and healthy individuals: a 2-year prospective study. British Journal of Ophthalmology 108:84−90

doi: 10.1136/bjo-2022-321603
[7]

Huang Y, Zhang N, Bulloch G, Zhang S, Shang X, et al. 2023. Rates of choroidal and neurodegenerative changes over time in diabetic patients without retinopathy: a 3-year prospective study. American Journal of Ophthalmology 246:10−19

doi: 10.1016/j.ajo.2022.07.011
[8]

Koh VT, Tham YC, Cheung CY, Wong WL, Baskaran M, et al. 2012. Determinants of ganglion cell–inner plexiform layer thickness measured by high-definition optical coherence tomography. Investigative Opthalmology & Visual Science 53:5853−5859

doi: 10.1167/iovs.12-10414
[9]

Lee YP, Ju YS, Choi DG. 2018. Ganglion cell-inner plexiform layer thickness by swept-source optical coherence tomography in healthy Korean children: normative data and biometric correlations. Scientific Reports 8:10605

doi: 10.1038/s41598-018-28870-4
[10]

Tham YC, Chee ML, Dai W, Lim ZW, Majithia S, et al. 2020. Profiles of ganglion cell-inner plexiform layer thickness in a multi-ethnic Asian population: the Singapore epidemiology of eye diseases study. Ophthalmology 127:1064−1076

doi: 10.1016/j.ophtha.2020.01.055
[11]

Lim HB, Shin YI, Lee MW, Koo H, Lee WH, et al. 2020. Ganglion cell – inner plexiform layer damage in diabetic patients: 3-year prospective, longitudinal, observational study. Scientific Reports 10:1470

doi: 10.1038/s41598-020-58465-x
[12]

Kim YK, Ha A, Na KI, Kim HJ, Jeoung JW, et al. 2017. Temporal relation between macular ganglion cell–inner plexiform layer loss and peripapillary retinal nerve fiber layer loss in glaucoma. Ophthalmology 124:1056−1064

doi: 10.1016/j.ophtha.2017.03.014
[13]

Lee WJ, Kim YK, Park KH, Jeoung JW. 2017. Trend-based analysis of ganglion cell–inner plexiform layer thickness changes on optical coherence tomography in glaucoma progression. Ophthalmology 124:1383−1391

doi: 10.1016/j.ophtha.2017.03.013
[14]

Abdolrahimzadeh S, Gharbiya M, Formisano M, Bertini F, Cerini A, et al. 2019. Anti-vascular endothelial growth factor intravitreal therapy and macular ganglion cell layer thickness in patients with neovascular age-related macular degeneration. Current Eye Research 44:1000−1005

doi: 10.1080/02713683.2019.1610179
[15]

Mutlu U, Colijn JM, Ikram MA, Bonnemaijer PWM, Licher S, et al. 2018. Association of retinal neurodegeneration on optical coherence tomography with dementia: a population-based study. JAMA Neurology 75:1256−1263

doi: 10.1001/jamaneurol.2018.1563
[16]

Wang W, He M, Huang W. 2017. Changes of retinal nerve fiber layer thickness in obstructive sleep apnea syndrome: a systematic review and meta-analysis. Current Eye Research 42:796−802

doi: 10.1080/02713683.2016.1238942
[17]

Zhang S, Chen Y, Wang L, Li Y, Tang X, et al. 2023. Design and baseline data of the diabetes registration study: Guangzhou diabetic eye study. Current Eye Research 48:591−599

doi: 10.1080/02713683.2023.2182745
[18]

Ye Z, Gao Y, Xie E, Li Y, Guo Z, et al. 2022. Evaluating the predictive value of diabetes mellitus diagnosed according to the Chinese guidelines (2020 edition) for cardiovascular events. Diabetology & Metabolic Syndrome 14:138

doi: 10.1186/s13098-022-00906-w
[19]

Levey AS, Coresh J, Tighiouart H, Greene T, Inker LA. 2020. Measured and estimated glomerular filtration rate: current status and future directions. Nature Reviews Nephrology 16:51−64

doi: 10.1038/s41581-019-0191-y
[20]

Mahmoudinezhad G, Moghimi S, Nishida T, Latif K, Yamane M, et al. 2023. Association between rate of ganglion cell complex thinning and rate of central visual field loss. JAMA Ophthalmology 141:33−39

doi: 10.1001/jamaophthalmol.2022.4973
[21]

Mwanza JC, Durbin MK, Budenz DL, Girkin CA, Leung CK, et al. 2011. Profile and predictors of normal ganglion cell–inner plexiform layer thickness measured with frequency-domain optical coherence tomography. Investigative Opthalmology & Visual Science 52:7872−7879

doi: 10.1167/iovs.11-7896
[22]

Kim NR, Kim JH, Lee J, Lee ES, Seong GJ, Kim CY. 2011. Determinants of perimacular inner retinal layer thickness in normal eyes measured by Fourier-domain optical coherence tomography. Investigative Opthalmology & Visual Science 52:3413−3418

doi: 10.1167/iovs.10-6648
[23]

Kang SH, Hong SW, Im SK, Lee SH, Ahn MD. 2010. Effect of myopia on the thickness of the retinal nerve fiber layer measured by Cirrus HD optical coherence tomography. Investigative Ophthalmology & Visual Science 51:4075−4083

doi: 10.1167/iovs.09-4737
[24]

Xu X, Xiao H, Lai K, Guo X, Luo J, et al. 2021. Determinants of macular ganglion cell–inner plexiform layer thickness in normal Chinese adults. BMC Ophthalmology 21:267

doi: 10.1186/s12886-021-02023-0
[25]

Son JR, Lee MJ, Jeon CJ. 2023. Changes in starburst amacrine cells in mice with diabetic retinopathy. Frontiers in Bioscience-Landmark 28:92

doi: 10.31083/j.fbl2805092
[26]

Albertos-Arranz H, Martínez-Gil N, Sánchez-Sáez X, Molina-Martín JC, Lax P, et al. 2025. Neuronal degeneration and glial activation in the absence of vascular changes in human retinas of patients with diabetes. Investigative Ophthalmology & Visual Science 66:53

doi: 10.1167/iovs.66.3.53
[27]

Carpi-Santos R, de Melo Reis RA, Gomes FCA, Calaza KC. 2022. Contribution of Müller cells in the diabetic retinopathy development: focus on oxidative stress and inflammation. Antioxidants 11:617

doi: 10.3390/antiox11040617
[28]

van Dijk HW, Verbraak FD, Kok PHB, Garvin MK, Sonka M, et al. 2010. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Investigative Opthalmology & Visual Science 51:3660−3665

doi: 10.1167/iovs.09-5041
[29]

Ebneter A, Chidlow G, Wood JP, Casson RJ. 2011. Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma. Archives of Ophthalmology 129:1337−1344

doi: 10.1001/archophthalmol.2011.269
[30]

Hou H, Shoji T, Zangwill LM, Moghimi S, Saunders LJ, et al. 2018. Progression of primary open-angle glaucoma in diabetic and nondiabetic patients. American Journal of Ophthalmology 189:1−9

doi: 10.1016/j.ajo.2018.02.002
[31]

Farias LB, Lavinsky D, Benfica CZ, Lavisnky J, Canani LH. 2018. Microalbuminuria is associated with early retinal neurodegeneration in patients with type 2 diabetes. Ophthalmic Surgery, Lasers and Imaging Retina 49:e36−e43

doi: 10.3928/23258160-20180907-05
[32]

Guo X, Zhu Z, Bulloch G, Huang W, Wang W. 2024. Impacts of chronic kidney disease on retinal neurodegeneration: a cross-cohort analysis. American Journal of Ophthalmology 258:173−182

doi: 10.1016/j.ajo.2023.10.005
[33]

Wang L, Jin L, Wang W, Gong X, Li Y, et al. 2023. Association of renal function with diabetic retinopathy and macular oedema among Chinese patients with type 2 diabetes mellitus. Eye 37:1538−1544

doi: 10.1038/s41433-022-02173-5